相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Systematic Review and Meta-analyses of Longitudinal Studies on Drug Treatments for Gaucher Disease
Leticia Paula Leonart et al.
ANNALS OF PHARMACOTHERAPY (2023)
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers
Gian Pal et al.
ANNALS OF NEUROLOGY (2022)
Neuroimaging alterations in dementia with Lewy bodies and neuroimaging differences between dementia with Lewy bodies and Alzheimer's disease: An activation likelihood estimation meta-analysis
Wen-ying Ma et al.
CNS NEUROSCIENCE & THERAPEUTICS (2022)
Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson's disease: mutational spectrum and clinical features
Jia Lun Lim et al.
JOURNAL OF NEURAL TRANSMISSION (2022)
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study
Aleksandra A. Szwedo et al.
MOVEMENT DISORDERS (2022)
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
Matthew Surface et al.
MOVEMENT DISORDERS (2022)
Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy
Jacob I. Ayers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
Shirley Yin-Yu Pang et al.
TRANSLATIONAL NEURODEGENERATION (2022)
Misfolded GBA/β-glucocerebrosidase impairs ER-quality control by chaperone-mediated autophagy in Parkinson disease
Sheng-Han Kuo et al.
AUTOPHAGY (2022)
Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote alpha-synuclein aggregation
Celine Galvagnion et al.
BRAIN (2022)
Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson's disease patients
Michela Leocadi et al.
JOURNAL OF NEUROLOGY (2022)
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
Nurit Omer et al.
MOVEMENT DISORDERS (2022)
Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review
Massimo Filippi et al.
MOVEMENT DISORDERS (2022)
Inflammation in dementia with Lewy bodies
Jay Amin et al.
NEUROBIOLOGY OF DISEASE (2022)
Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses
Li Liu et al.
NEUROLOGICAL SCIENCES (2022)
Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease: Pathogenesis and Therapeutic Implications
Wei Zheng et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith et al.
CELLS (2022)
Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells
Lucie Dupuis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease
Maria Kedariti et al.
NPJ PARKINSONS DISEASE (2022)
Redefining GBA gene structure unveils the ability of Cap-independent, IRES-dependent gene regulation
Keiko Miyoshi et al.
COMMUNICATIONS BIOLOGY (2022)
Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy
Sheng-Han Kuo et al.
SCIENCE ADVANCES (2022)
The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease
Sonia Sanz Munoz et al.
BIOPHYSICAL CHEMISTRY (2021)
Human α-synuclein overexpression in a mouse model of Parkinson's disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
Osama Elabi et al.
SCIENTIFIC REPORTS (2021)
Successful Treatment of Gaucher Disease With Matched Sibling Hematopoietic Stem Cell Transplantation
Shevachut Chavananon et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2021)
APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Chia-Chen Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Cognitive Functioning of Glucocerebrosidase (GBA) Non-manifesting Carriers
Eileen E. Moran et al.
FRONTIERS IN NEUROLOGY (2021)
Association of gender and age at onset with glucocerebrosidase associated Parkinson's disease: a systematic review and meta-analysis
Qinghua Li et al.
NEUROLOGICAL SCIENCES (2021)
Spastic paraplegia type 46: novel and recurrent GBA2 gene variants in a compound heterozygous Italian patient with spastic ataxia phenotype
Marta Gatti et al.
NEUROLOGICAL SCIENCES (2021)
Gene Therapy for Parkinson's Disease Associated with GBA1 Mutations
Asa Abeliovich et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Exploring the Genotype-Phenotype Correlation in GBA-Parkinson Disease: Clinical Aspects, Biomarkers, and Potential Modifiers
Elisa Menozzi et al.
FRONTIERS IN NEUROLOGY (2021)
Next-Generation Sequencing Analysis of GBA1: The Challenge of Detecting Complex Recombinant Alleles
Elizabeth G. Woo et al.
FRONTIERS IN GENETICS (2021)
FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
Kejal Kantarci et al.
NEUROIMAGE-CLINICAL (2021)
Anosognosia in dementia with Lewy bodies: a systematic review
Victor Calil et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2021)
Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology
Elie Matar et al.
JOURNAL OF NEUROLOGY (2020)
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles
Stefanie Lerche et al.
MOVEMENT DISORDERS (2020)
LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks
Katharina A. Schindlbeck et al.
CEREBRAL CORTEX (2020)
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni et al.
LANCET NEUROLOGY (2020)
Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni et al.
MOVEMENT DISORDERS (2020)
Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease
Amokelani C. Mahungu et al.
NEUROBIOLOGY OF AGING (2020)
A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease
Elma Aflaki et al.
NEUROBIOLOGY OF DISEASE (2020)
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation
Shi-yu Yang et al.
NEUROBIOLOGY OF DISEASE (2020)
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
Michael X. Henderson et al.
NEURON (2020)
Management of mild cognitive impairment (MCI): The need for national and international guidelines
Siegfried Kasper et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2020)
Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease
Thomas B. Stoker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease
Micol Avenali et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations
Philip W. Tipton et al.
PARKINSONISM & RELATED DISORDERS (2020)
Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease
Elisa Menozzi et al.
CNS DRUGS (2020)
Neuroinflammation in dementia with Lewy bodies: a human post-mortem study
Jay Amin et al.
TRANSLATIONAL PSYCHIATRY (2020)
Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
Diana A. Olszewska et al.
FRONTIERS IN NEUROLOGY (2020)
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies
Yuxing Xia et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
Jonas M. den Heijer et al.
MOVEMENT DISORDERS (2020)
Penetrance of Glucocerebrosidase (GBA) Mutations in Parkinson's Disease: a Kin Cohort Study
Roberta Balestrino et al.
MOVEMENT DISORDERS (2020)
GBA-RelatedParkinson's Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort
Simona Petrucci et al.
MOVEMENT DISORDERS (2020)
β-Glucocerebrosidase activity in GBA-linked Parkinson disease The type of mutation matters
Young Eun Huh et al.
NEUROLOGY (2020)
GBA variation and susceptibility to multiple system atrophy
Anna I. Wernick et al.
PARKINSONISM & RELATED DISORDERS (2020)
GBAVariants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes
Andrea Greuel et al.
MOVEMENT DISORDERS (2020)
Microglia and astrocyte dysfunction in parkinson's disease
Tae-In Kam et al.
NEUROBIOLOGY OF DISEASE (2020)
Structural imaging in dementia with Lewy bodies: the potential of multivariate data analysis
Daniel Ferreira
PSYCHIATRY RESEARCH-NEUROIMAGING (2020)
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients
Roy N. Alcalay et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
The Cognitive Profile of Mild Cognitive Impairment Due to Dementia With Lewy Bodies-An Updated Review
Mathilde Suhr Hemminghyth et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Protein-based amide proton transfer-weighted MR imaging of amnestic mild cognitive impairment
Zewen Zhang et al.
NEUROIMAGE-CLINICAL (2020)
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
Hongyu Li et al.
AUTOPHAGY (2019)
GBA mutations p.N370S and p.L444P are associated with Parkinson's disease in patients from Northern Brazil
Carlos Eduardo de Melo Amaral et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2019)
Pharmacological Management of Dementia with Lewy Bodies
Linda A. Hershey et al.
DRUGS & AGING (2019)
Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease
D. Arkadir et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Clinical Presentation, Diagnostic Features, and Mortality in Dementia with Lewy Bodies
Sinead Moylett et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru
Carlos Velez-Pardo et al.
PARKINSONISM & RELATED DISORDERS (2019)
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
Silvia Paola Caminiti et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases
Jiaming Zhang et al.
FRONTIERS IN NEUROSCIENCE (2019)
Autonomic Dysfunction in α-Synucleinopathies
Jose Javier Mendoza-Velasquez et al.
FRONTIERS IN NEUROLOGY (2019)
GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta M. Riboldi et al.
CELLS (2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study
Micol Avenali et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers
Stephen Mullin et al.
MOVEMENT DISORDERS (2019)
Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype
Benjamin Liou et al.
SCIENTIFIC REPORTS (2019)
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
Arvid Rongve et al.
SCIENTIFIC REPORTS (2019)
The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
Ito Kawakami et al.
ACTA NEUROPATHOLOGICA (2019)
Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do et al.
MOLECULAR NEURODEGENERATION (2019)
Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics
Konstantin Senkevich et al.
PARKINSONISM & RELATED DISORDERS (2019)
A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease
Lena F. Burbulla et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Dementia with Lewy bodies: an update and outlook
Tiago Fleming Outeiro et al.
MOLECULAR NEURODEGENERATION (2019)
Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts
Hirotaka Iwaki et al.
NEUROLOGY-GENETICS (2019)
UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease
Hila Braunstein et al.
BLOOD CELLS MOLECULES AND DISEASES (2018)
GBA-Associated Parkinson's Disease and Other Synucleinopathies
Ziv Gan-Or et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study
Junji Komatsu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study
Naveed Malek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood
Laia Perez-Roca et al.
AGING AND DISEASE (2018)
Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis
Yuan Zhang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
Oeystein R. Brekk et al.
SCIENTIFIC REPORTS (2018)
Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease
Iva Stojkovska et al.
CELL AND TISSUE RESEARCH (2018)
Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies
John H. T. Power et al.
BRAIN PATHOLOGY (2017)
Insights into the structural biology of Gaucher disease
Laura Smith et al.
EXPERIMENTAL NEUROLOGY (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Nahid Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology
Yuyuan Gao et al.
NEUROSCIENCE LETTERS (2017)
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal
Victoria Berge-Seidl et al.
NEUROSCIENCE LETTERS (2017)
A dose effect of mutations in the GBA gene on Parkinson's disease phenotype
Avner Thaler et al.
PARKINSONISM & RELATED DISORDERS (2017)
Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study
Annabel Price et al.
BMJ OPEN (2017)
A molecular analysis of the GBA gene in Caucasian South Africans with Parkinson's disease
Melinda Barkhuizen et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2017)
Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
Elma Aflaki et al.
AGING CELL (2016)
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2016)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
Glucocerebrosidase and parkinsonism: lessons to learn
Ivanka Markovic et al.
JOURNAL OF NEUROLOGY (2016)
Neuropsychiatric characteristics of GBA-associated Parkinson disease
Matthew Swan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies
Ana Gamez-Valero et al.
MOVEMENT DISORDERS (2016)
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
Rita Guerreiro et al.
NEUROBIOLOGY OF AGING (2016)
GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease
Silvia Jesus et al.
PLOS ONE (2016)
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews
Tamara Shiner et al.
JAMA NEUROLOGY (2016)
Lack of enzyme activity in GBA2 mutants associated with hereditary spastic paraplegia/cerebellar ataxia (SPG46)
Saki Sultana et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
The Synaptic Function of α-Synuclein
Jacqueline Burre
JOURNAL OF PARKINSONS DISEASE (2015)
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation-Positive Cohort
Michelle Beavan et al.
JAMA NEUROLOGY (2015)
GBA-Associated Parkinson's Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2015)
Variants associated with Gaucher disease in multiple system atrophy
Jun Mitsui et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Functional analysis of 11 novel GBA alleles
Erika Malini et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2014)
Glucocerebrosidase mutations in primary parkinsonism
Rosanna Asselta et al.
PARKINSONISM & RELATED DISORDERS (2014)
LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance
Michelle Rothaug et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
David C. Schoendorf et al.
NATURE COMMUNICATIONS (2014)
Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein
Eun-Jin Bae et al.
NATURE COMMUNICATIONS (2014)
Saposin C Protects Glucocerebrosidase against α-Synuclein Inhibition
Thai Leong Yap et al.
BIOCHEMISTRY (2013)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort
Sophie E. Winder-Rhodes et al.
BRAIN (2013)
Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease-Links to Parkinson's Disease
Laura D. Osellame et al.
CELL METABOLISM (2013)
Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
Thai Leong Yap et al.
MOLECULAR GENETICS AND METABOLISM (2013)
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
Michael A. Nalls et al.
JAMA NEUROLOGY (2013)
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine et al.
JAMA NEUROLOGY (2013)
The link between the GBA gene and parkinsonism
Ellen Sidransky et al.
LANCET NEUROLOGY (2012)
Glucocerebrosidase Gene Mutations Are Associated with Parkinson's Disease in Russia
Anton Emelyanov et al.
MOVEMENT DISORDERS (2012)
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
M. Anheim et al.
NEUROLOGY (2012)
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
R. N. Alcalay et al.
NEUROLOGY (2012)
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation
Nick Dekker et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
Thai Leong Yap et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa
S. Lesage et al.
NEUROLOGY (2011)
Gaucher Disease Ascertained Through a Parkinson's Center: Imaging and Clinical Characterization
Rachel Saunders-Pullman et al.
MOVEMENT DISORDERS (2010)
Mutations for Gaucher Disease Confer High Susceptibility to Parkinson Disease
Jun Mitsui et al.
ARCHIVES OF NEUROLOGY (2009)
Genetic susceptibility in Parkinson's disease
Jose Miguel Bras et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
W. C. Nichols et al.
NEUROLOGY (2009)
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece
Kallirhoe Kalinderi et al.
NEUROSCIENCE LETTERS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Kathleen S. Hruska et al.
HUMAN MUTATION (2008)
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy
Elvira V. De Marco et al.
MOVEMENT DISORDERS (2008)
Murine models of acute neuronopathic Gaucher disease
Ida Berglin Enquist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients
Eng-King Tan et al.
ARCHIVES OF NEUROLOGY (2007)
Hematologically important mutations: Gaucher disease
E Beutler et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Analysis of the glucocerebrosidase gene in Parkinson's disease
C Sato et al.
MOVEMENT DISORDERS (2005)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
Parkinsonism among Gaucher disease carriers
O Goker-Alpan et al.
JOURNAL OF MEDICAL GENETICS (2004)
Expression and functional characterization of mutated glucocerebrosidase alleles causing Gaucher disease in Spanish patients
P Alfonso et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease
H Dvir et al.
EMBO REPORTS (2003)